📰 Roberta Hauser News
Roberta Hauser News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roberta Hauser. Real-time updates on events, politics, business and more.
August 30, 2023
Analyses of pivotal study data of Dysport® reveal a large proportion of study patients did not require retreatment for at least 12 weeks This new analysis...
August 24, 2023
- IPX203 demonstrated statistically significant improvement in daily “Good On” time compared to optimized IR CD/LD, with fewer daily doses ...
November 8, 2022
/PRNewswire/ -- Vial welcomes Robert A. Hauser, MD, MBA, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Hauser is the...
July 27, 2022
GuruFocus Article or News written by Business Wire and the topic is about:
June 13, 2022
Phase 1/1b 101 study terminated early; demonstrated favorable safety, tolerability, and pharmacokinetic profile in single doses up to 325 mg and...
April 6, 2022
Formulated for longer activity, symptoms stay suppressed until time for next dose
December 15, 2021
/PRNewswire/ -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on reformulation and combinations of previously approved...
December 15, 2021
/PRNewswire/ -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on reformulation and combinations of previously approved...
December 15, 2021
/PRNewswire/ -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based on reformulation and combinations of previously approved...
December 15, 2021
Study successfully met its primary and key secondary endpoints, demonstrating superior efficacy of P2B001 compared to its individual components P2B001 showed comparable efficacy to a marketed